Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Milton H. Werner currently holds 45,000 shares of Inhibikase Therapeutics, Inc. (IKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Milton H. Werner has been a net buyer of IKT stock. They have purchased $61.5K and sold $0 worth of shares.
Milton H. Werner's most recent insider trade was on Apr 1, 2024, when they sold 45,000 shares at $0.00 per share.
Milton H. Werner serves as Executive at Inhibikase Therapeutics, Inc. (IKT). They have executed 13 insider transactions totaling $61.5K over their tenure at the company.
Milton H. Werner holds the position of Executive at Inhibikase Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Milton H. Werner has shown a buying trading pattern, with $61.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Milton H. Werner was on May 14, 2021, when they sold $77.7K worth of IKT shares. This transaction involved 16,918 shares at $4.59 per share.
Milton H. Werner currently owns 45,000 shares of Inhibikase Therapeutics, Inc. (IKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Milton H. Werner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Milton H. Werner has 13 Form 4 filings on record as an insider at Inhibikase Therapeutics, Inc..
Set alerts for Milton H. Werner and 40,000+ other insiders.